Navigation Links
Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
Date:6/23/2011

ulate in the blood after each meal. When such particles, called chylomicrons, accumulate in the blood, they may obstruct small blood vessels. Excess chylomicrons result in recurrent and severe acute inflammation of the pancreas, called pancreatitis, the most debilitating complication of LPLD. Glybera® has orphan drug status in the EU and US.

About Amsterdam Molecular Therapeutics

AMT is a world leader in the development of human gene based therapies. In addition to Glybera, AMT has a product pipeline of several gene therapy products in development for hemophilia B, Duchenne muscular dystrophy, acute intermittent porphyria, Parkinson's disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate probably the world's first stable and scalable AAV manufacturing platform. This proprietary platform can be applied to a large number of rare (orphan) diseases caused by one faulty gene and allows AMT to pursue its strategy of focusing on this sector of the industry.  AMT was founded in 1998 and is based in Amsterdam. Further information can be found at http://www.amtbiopharma.com.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy,""expects,"" plans,""anticipates,""believes, ""will,""continues," "estimates,""intends,"" projects,""goals,""targets " and other words of similar meaning are intended to identify such f
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharma and Food Thought Leaders Set to Converge in Amsterdam Next April 2011
2. Amsterdam Molecular Therapeutics Reports Promising Data From Cholesterol Lowering Gene Therapy Study
3. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
4. Latest Molecular Diagnostics Technology Aids German Hospital in Management of European E. coli Crisis
5. Data from Clinical Studies of bioTheranostics CancerTYPE ID® and Breast Cancer Index(SM) Molecular Diagnostic Tests Presented at ASCO 2011 Annual Meeting
6. ImaginAb, Inc. Announces Availability of Custom Protein Radiolabeling Services for Molecular Imaging
7. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
8. The World Leader in Molecular Breast Imaging to Premiere Largest Detector in the Industry
9. Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
10. Latest Clinical Evidence Supports Promising Outlook for Low-Dose Molecular Breast Imaging (MBI)
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
(Date:3/27/2015)... 2015  WebMD Health Corp. (NASDAQ: ... information, today announced an exclusive White House ... Plan for Combating Antibiotic-Resistant Bacteria . During ... and importance of addressing antibiotic-resistant bacteria and ... The WebMD interview, available online ...
(Date:3/26/2015)... Huntington Memorial Hospital is the first facility ... valve replacement (TAVR), a minimally invasive replacement of heart ... to replace an aortic valve without a chest incision ... The procedure is performed by a dedicated Huntington ... Durairaj , MD, interventional cardiologist and Robbin Cohen ...
Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2
... , July 1 Samplify Systems, Inc., a leading provider of ... providing a local presence to better serve customers interested in the company,s ... Xu , who joins Samplify as Country Sales Director.   , ... (Logo: http://photos.prnewswire.com/prnh/20080411/AQF028LOGO ) , ...
... July 1 Caraco Pharmaceutical Laboratories, Ltd. ... tartrate capsules. These products, approved by the US Food ... Drug Application (ANDA), are therapeutically equivalent to Exelon® capsules ... mild to moderate Alzheimer,s dementia and mild to moderate ...
Cached Medicine Technology:Samplify Expands Global Presence; Opens China Office 2Samplify Expands Global Presence; Opens China Office 3Samplify Expands Global Presence; Opens China Office 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Exelon® Capsules 2
(Date:3/27/2015)... While deep learning was the topic of many ... , the CEO of one start-up spoke passionately about using ... well beyond the generally-agreed ceiling of 120 years. , Insilico ... of 12 companies recognized as the hottest GPU-powered startups in ... GTC Emerging Companies Summit have business models focused on ...
(Date:3/27/2015)... Detroit, Michigan (PRWEB) March 27, 2015 ... Field, LiveToBeSober.org, along with former Detroit Lions wide ... informal luncheon and educational presentation on substance abuse, ... legislation. Among those who attended were pastors, ministers ... civic leaders and other distinguished guests. , “Our ...
(Date:3/27/2015)... 27, 2015 GenSight, the leading Enterprise ... Sean Fitzgerald, a former technology and financial executive to ... Interim Chief Financial Officer. , Mr Fitzgerald was most ... EverFi, backed by Amazon founder and CEO Jeff Bezos, ... Prior to EverFi, he was a Senior Vice President ...
(Date:3/27/2015)... WA (PRWEB) March 27, 2015 When ... can be hard to know where to begin. The ... experienced Seattle trucking accident attorney, offers accident victims a ... and legal assistance to ensure their personal injury claim ... begins by describing the first actions that should be ...
(Date:3/27/2015)... MN (PRWEB) March 27, 2015 ... Minnesotans for Healthy Kids Coalition Lobby Day to ... Statewide Health Improvement Program (SHIP). Everlast Climbing ... 2015 PE Bill SF343/HF498 which would strengthen physical ... annual student assessments and other measures to strengthen ...
Breaking Medicine News(10 mins):Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2
... off ,superbugs, , , MONDAY, April 7 (HealthDay News) -- Call ... alligator blood could serve as the basis for new antibiotics ... , The research is in its early stages -- extracts ... -- and there,s no guarantee that it will work in ...
... Association Intervention Tool Kit Reduces Patient ... Injuries/Repeat Visits and Risky Drinking, DES ... Alcohol Screening Day, 360 nurses in emergency departments,nationwide will ... intervention tool kit designed to address alcohol use,problems with ...
... science education, scientific research, and the role science should play in ... ... NEW YORK, April 7, 2008 Since its launch in October,2006, the ... human health issues facing the 21st century, including the,brain, the human genome, ...
... NEW YORK, April 7, 2008 In celebration ... Tuesday, April 15, a biodiesel-fueled,eco-salon and spa bus ... around,Southern California from Tuesday, April 15, 2008 - ... shopping areas and attractions., The general public ...
... April 7, 2008 Edmond Medical Center and,ophthalmologists M. ... Regional Eye Associates, will once again participate in the ... surgeries,for those who cannot afford to pay., Appointments ... physicians,office. If the patient qualifies for the cataract surgery ...
... that estrogen replacement therapy (ERT) may increase the risk of ... adverse effects of ERT are related to the doses used. ... increased problems in the kidney and heart. These results suggest ... womans overall health. , The study, Dose-Response Effect of ...
Cached Medicine News:Health News:Gator Blood May Be New Source of Antibiotics 2Health News:Gator Blood May Be New Source of Antibiotics 3Health News:Emergency Departments Nationwide Institute New Alcohol Screening and Intervention Process 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 2Health News:Charlie Rose Science Series Wraps Up With Episode on 'The Imperative and Promise of Science' 3Health News:ELLE Eco-Salon & Spa Rolls Thru Southern California Offering Styling, Mini- Makeovers and Beauty Treatments 2Health News:Edmond Medical Center to Provide Free Cataract Surgeries 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 2Health News:New study finds adverse effects of estrogen replacement therapy are related to the dose 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: